CD274 and neoplasm: The recent demonstration that ATC is characterized by a high tumor mutation burden, a high level of PD-L1 expression, a high level of TIL infiltration together with the safety of ICIs 98 all renew the interest in using immunotherapy against this deadly TC 100.